Description
Elsevier SGLT-2 Inhibitors An Issue of Heart Failure Clinics 1st Edition by Bhatt, Deepak L.
In this issue, guest editors bring their considerable expertise to this important topic.Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Glucose-Lowering and Metabolic Effects of SGLT2 InhibitorsRenoprotective Effects of SGLT2 InhibitorsSGLT2 Inhibitors in Type 2 Diabetes MellitusSGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: A Paradigm Shift Toward Dual Cardio-Renal ProtectionSGLT2 Inhibitors and Heart Failure with Preserved Ejection FractionSGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical BenefitsSodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease EventsSGLT2 Inhibitors and Peripheral Vascular Events: A Review of the LiteratureSodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver DiseaseSGLT2 Inhibitors and Safety in Older PatientsSodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk